Cargando…
Successes and challenges in modeling heterogeneous BRAF(V600E) mutated central nervous system neoplasms
Central nervous system (CNS) neoplasms are difficult to treat due to their sensitive location. Over the past two decades, the availability of patient tumor materials facilitated large scale genomic and epigenomic profiling studies, which have resulted in detailed insights into the molecular underpin...
Autores principales: | Xing, Yao Lulu, Panovska, Dena, Petritsch, Claudia K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619673/ https://www.ncbi.nlm.nih.gov/pubmed/37920169 http://dx.doi.org/10.3389/fonc.2023.1223199 |
Ejemplares similares
-
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
por: Behling, Felix, et al.
Publicado: (2016) -
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018) -
BRAF Alteration in Central and Peripheral Nervous System Tumors
por: Srinivasa, Komal, et al.
Publicado: (2020) -
Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
por: Di Nunno, Vincenzo, et al.
Publicado: (2023) -
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
por: Consoli, Francesca, et al.
Publicado: (2020)